Fuchs Endothelial Corneal Dystrophy

Overview

Fuchs endothelial corneal dystrophy (FECD) is a progressive, bilateral disorder of the corneal endothelium characterized by accelerated endothelial cell loss and the formation of excrescences on Descemet's membrane called guttae, ultimately leading to corneal edema, reduced vision, and (in advanced cases) pain from bullous keratopathy.² It is among the most common indications for corneal transplantation worldwide.

Epidemiology & Risk Factors

FECD is more common in women than men and typically presents after age 50, though guttae can be detected earlier. A CTG trinucleotide repeat expansion in the TCF4 gene is strongly associated with FECD: in one study of Swedish cases, a repeat expansion (>50 repeats) was identified in the large majority of FECD cases and only a small minority of controls, and a higher number of repeats was associated with greater disease severity.¹ Ocular surgery has been proposed as a possible environmental factor contributing to FECD in patients without a TCF4 repeat expansion, suggesting more than one pathway to the phenotype.¹ A preliminary study has also suggested an association between higher lifetime estrogen exposure and greater FECD severity in women, though this finding is based on a small sample and requires confirmation.³

Pathophysiology

The corneal endothelium is a single, non-regenerating layer of cells responsible for actively pumping fluid out of the stroma to maintain corneal deturgescence (relative dehydration) and transparency. In FECD, progressive endothelial cell loss and dysfunction — associated with the TCF4 repeat expansion in most cases — reduces this pumping capacity below the threshold needed to keep the stroma dehydrated, leading to stromal and eventually epithelial edema once endothelial cell density falls critically low. Guttae (focal excrescences of abnormal collagen on Descemet's membrane) are an early, visible marker of this endothelial dysfunction, often preceding clinically significant edema by years.

Clinical Presentation

Early FECD is often asymptomatic, with guttae noted incidentally on slit-lamp exam. As endothelial function declines, patients report blurred vision that is characteristically worse in the morning (from overnight stromal fluid accumulation during eyelid closure, when evaporation is reduced) and improves somewhat through the day. Advanced disease produces persistent blur, glare, and, when bullae (fluid-filled epithelial blisters) form and rupture, significant pain.

Exam Findings

• Guttae: refractile, "beaten-metal" excrescences on the corneal endothelium, best seen with specular reflection at the slit lamp
• Stromal edema/thickening, measurable by increased central corneal thickness (pachymetry)
• Epithelial or subepithelial bullae in advanced disease
• Reduced endothelial cell density and pleomorphism/polymegathism on specular microscopy
• Corneal haze or scarring in longstanding advanced disease

Differential Diagnosis

• Pseudophakic/aphakic bullous keratopathy (endothelial decompensation from surgical trauma rather than primary dystrophy — often clinically indistinguishable without surgical history)
• Posterior polymorphous corneal dystrophy
• Congenital hereditary endothelial dystrophy (presents in infancy)
• Other causes of corneal edema (e.g., acute hydrops in keratoconus, though the mechanism and population differ substantially)
• Myotonic dystrophy type 1, which can produce a mild corneal phenotype with guttae-like changes even without TCF4 repeat expansion

Management

Diagnosis is based on slit-lamp identification of guttae plus supportive findings on pachymetry and specular microscopy (reduced endothelial cell density, pleomorphism). Early, asymptomatic disease is simply observed. Mild symptomatic disease (morning blur) can be managed with hypertonic saline drops or ointment to help draw fluid from the cornea, and a hairdryer (held at arm's length, cool setting) to hasten evaporation of overnight edema.

For advanced disease with significant vision loss, Descemet membrane endothelial keratoplasty (DMEK) — selectively replacing only the diseased Descemet's membrane and endothelium — has become the preferred surgical treatment over full-thickness penetrating keratoplasty, offering faster visual recovery and lower rejection rates, though it carries a distinct learning curve for surgeons and a risk of graft detachment requiring rebubbling (injection of air/gas to re-appose the graft).² Common indications for DMEK include FECD, pseudophakic/aphakic bullous keratopathy, and prior graft failure.

Complications

• Bullous keratopathy with pain from ruptured epithelial bullae in advanced untreated disease
• Post-DMEK graft detachment requiring rebubbling (a relatively common early postoperative event)
• Post-DMEK elevation in intraocular pressure, an important complication requiring monitoring
• Intraoperative complications such as aqueous misdirection or anterior chamber fibrin reaction, which are recognized surgical challenges during DMEK

Clinical Pearls

• Guttae are often visible on exam years before symptomatic corneal edema develops — document and monitor even in asymptomatic patients
• Morning blur that improves through the day is a classic early symptom of FECD, from overnight fluid accumulation during lid closure
• DMEK has become the preferred surgical approach over full-thickness penetrating keratoplasty for FECD, given faster recovery and lower rejection risk²
• Elevated postoperative intraocular pressure is a clinically important complication to monitor for after DMEK
• TCF4 repeat expansion is strongly associated with FECD, but ocular surgery may act as an alternative environmental contributor in patients without the repeat expansion¹

Common Pitfalls

• Attributing morning blur solely to dry eye or refractive fluctuation without examining for guttae and stromal edema
• Assuming pseudophakic bullous keratopathy is a separate, unrelated diagnosis rather than considering underlying subclinical FECD that decompensated after cataract surgery
• Underestimating the risk of graft detachment/rebubbling after DMEK when counseling patients preoperatively
• Overlooking postoperative intraocular pressure elevation as a complication requiring monitoring after DMEK
• Assuming all corneal edema in an older patient is due to FECD without considering other causes such as prior surgical trauma